Back
Kodiak Sciences Vs. Acumen Pharmaceuticals Industry Stock Comparison
Buy
62
KOD
Kodiak Sciences
Last Price:
5.92
Seasonality Move:
24.46%
Sell
14
ABOS
Acumen Pharmaceuticals
Last Price:
2.31
Seasonality Move:
-0.29%
Buy
62
Kodiak Sciences (KOD)
is a Buy
Is Kodiak Sciences a Buy, Sell or Hold?
- The current Kodiak Sciences [KOD] share price is $5.79. The Score for KOD is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KOD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
14
Acumen Pharmaceuticals (ABOS)
is a Sell
Is Acumen Pharmaceuticals a Buy, Sell or Hold?
- The current Acumen Pharmaceuticals [ABOS] share price is $2.37. The Score for ABOS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- ABOS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
KOD Stock Price Chart
What is Kodiak Sciences's stock price today?
-
The Kodiak Sciences share price today is $5.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KOD is experiencing slight buying pressure.
ABOS Stock Price Chart
What is Acumen Pharmaceuticals's stock price today?
-
The Acumen Pharmaceuticals share price today is $2.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing slight selling pressure.
KOD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.65 | Buy |
| Relative Strength Index (14 RSI): | 79.21 | Buy |
| Chaikin Money Flow: | 73411 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.58 - 5.26) | Buy |
| Bollinger Bands (100): | (2.21 - 3.99) | Buy |
ABOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 40.25 | Sell |
| Chaikin Money Flow: | -41653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.51 - 3.07) | Sell |
| Bollinger Bands (100): | (2.36 - 3.02) | Sell |
KOD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.48 | Buy |
| 20-day SMA: | 4.65 | Buy |
| 50-day SMA: | 3.53 | Buy |
| 200-day SMA: | 3.68 | Buy |
| 8-day EMA: | 5.42 | Buy |
| 20-day EMA: | 4.78 | Buy |
| 50-day EMA: | 3.93 | Buy |
| 200-day EMA: | 3.59 | Buy |
ABOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.56 | Sell |
| 20-day SMA: | 2.81 | Sell |
| 50-day SMA: | 2.61 | Sell |
| 200-day SMA: | 3.06 | Sell |
| 8-day EMA: | 2.53 | Sell |
| 20-day EMA: | 2.67 | Sell |
| 50-day EMA: | 2.68 | Sell |
| 200-day EMA: | 3.04 | Sell |
Kodiak Sciences Earnings Growth & KOD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and a decrease next year of $0.39 per share.
Acumen Pharmaceuticals Earnings Growth & ABOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and a decrease next year of $0.04 per share.
Kodiak Sciences Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Acumen Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||